Fluorescence Enhanced Theragnosis: A Principle that Serves to Educate and Provide Quality Assessment in Clinical Practice and Lab Training Part A Clinical Practice

Case Series

J Dent & Oral Disord. 2025; 11(1): 1189.

Fluorescence Enhanced Theragnosis: A Principle that Serves to Educate and Provide Quality Assessment in Clinical Practice and Lab Training – Part A – Clinical Practice

Gal Hiltch¹, Cauana Oliva Tavares¹, José Antonio Poli de Figueiredo¹*, Silvia Dias de Oliveira², Livia Ramos Alvariza¹, Daiane Giron Granzzoto¹ and Liviu Steier³

¹Federal University of Rio Grande do Sul – UFRGS – Graduate Program in Dentistry, Porto Alegre, Brazil

²Pontifical Catholic University of Rio Grande do Sul – PUCRS – Graduate Program in Dentistry, Porto Alegre, Brazil

³University of Pennsylvania – UPENN - School of Dental Medicine, Department of Preventive and Restorative Sciences, USA

*Corresponding author: José Antonio Poli de Figueiredo, Professor in Oral Biology and Endodontology – UFRGS Federal University of Rio Grande do Sul, Rua Sarmento Leite, 500 – room 134, CEP 90050-170 Porto Alegre, RS, Brazil Email: poli.figueiredo@outlook.com

Received: February 22, 2025; Accepted: March 20, 2025; Published: March 24, 2025;

Abstract

Objectives: This study aims to convey the educational possibilities of Fluorescence Enhanced Theragnosis (FET) in the Dental field. Early detection, diagnosis, and prediction of pathological activity are fundamental challenges in contemporary dentistry. Fluorescence-based diagnostic tools have emerged as valuable adjuncts in addressing these challenges. Human tissues and bacteria exhibit distinct bioluminescent properties, emitting different wavelengths and, consequently, producing distinct characteristic colour emissions under certain light conditions.

Materials and Methods: The authors present their clinical experience with the Reveal™ device (Designs For Vision Inc, NYC, New York, USA), which integrates 405 nm and 450 nm LED light sources into hands-free loupes, and demonstrates enhanced diagnostic capabilities and treatment decision-making. This configuration enables more conservative approaches and minimally invasive treatments tailored to each case. This paper presents the theragnosis concept through bioluminescence-based techniques in the oral cavity, supported by clinical cases that demonstrate this approach’s efficacy.

Results: Our findings establish fluorescence as both an educational tool and a clinical aid, enhancing the visualization, diagnosis, and treatment of diverse oral conditions through real-time assessment of pathological processes.

Conclusions: This phenomenon may provide dental students at all educational levels with an effective tool for identifying and understanding various oral conditions, including dental biofilm, white lesions, caries, periodontal disease, peri-implantitis, oral infections, potentially malignant lesions, and oral cancer.

Clinical Relevance: The implementation of Fluorescence Enhanced Theragnosis at early stages, particularly during undergraduate and graduate learning, may result in professionals with more precise diagnostic skills and able to provide minimally invasive interventions with outcomes that are adequate to patients´ needs.

Keywords: Dental biofilm; White lesions; Periodontal disease; Peri-implantitis; Oral infections; Oral cancer

Introduction

A conservative approach in dentistry relies on detecting and resolving pathological threats through minimally invasive and optimal treatment techniques while maintaining tissue balance [1]. Successful conservative dentistry relies on enhanced clinical decisionmaking capabilities supported by accurate diagnostic tools. Recently, non-invasive fluorescence-based diagnostic adjuncts have gained significant recognition for their contribution to diagnostic accuracy [2-9]. Fluorescence occurs when molecules absorb high-energy photons at shorter wavelengths and subsequently re-emit lower-energy photons at longer wavelengths, causing the surface containing these molecules to emit light or "luminescence" [10]. Both human tissues and bacteria possess natural biofluorescent properties, producing characteristic colors when exposed to an external blue light source. In the context of oral bacteria, this fluorescence primarily results from the excitation of specific molecules called porphyrins [11]. As the natural concentration of fluorescent molecules (endogenous fluorophores) varies among different bacteria and human cell types, additional chemical fluorophores can be introduced to enhance the fluorescent signal. These supplementary fluorophores are versatile, responding to different excitation wavelengths and emitting light across a wide range of colors in the visible spectrum [12].

The green and red autofluorescence characteristics of enamel, dentin, and dental plaque have been documented for over a century [13]. In dentistry, numerous specialties benefit from autofluorescence applications, ranging from carious lesion detection to oral cancer screening. Early detection, diagnosis, and prediction of lesion activity through this technique have garnered substantial interest. Notably, mature plaque exhibits red autofluorescence when illuminated with 405 nm blue light [14]. This red autofluorescence signature appears in various pathological conditions, including teeth with plaque accumulation, calculus deposits, infected implant surfaces, active caries, and stomatitis [4,15-19]. In contrast, healthy tissues display different spectral characteristics [13]. In oral cancer applications, normal soft tissue exhibits fluorescence, while potentially malignant lesions appear as dark regions [2].

Real-time, hands-free detection of infected tissues can be accomplished using a novel fluorescence-based magnification loupe equipped with a 405 nm LED light source: Reveal® (DesignsForVision Inc, NYC, New York, USA). This system is customized to the operator's specific optical requirements and provides magnification that overcomes limitations in visual, tactile, and radiological diagnosis. It embodies the theragnosis concept (combining diagnostic and therapeutic modalities), enabling comprehensive treatment guidance from initial diagnosis through the differentiation of healthy and diseased tissues, to treatment completion [20].

What is Fluorescence and How Does it Work?

Fluorescence is a physicochemical energy exchange phenomenon where molecules absorb shorter-wavelength photons and re-emit a part of their energy as longer wavelength photons. The surface or object containing the pigment molecule appears to glow due to this energy conversion, rather than through actual light production [10]. Bioluminescence, a related phenomenon, refers to the production of light by living organisms, occurring naturally across various biological kingdoms, including plants, animals, and humans [21-26].

The bioluminescent light emission process involves various enzymes and light-emitting molecules, notably luciferases and luciferins. The spectral range of this emission spans from 400 to 700 nm, corresponding to blue through red light. Importantly, the resulting fluorescence may differ from the object's intrinsic color reflection. While ultraviolet light is commonly associated with fluorescence excitation, blue or blue/green light can also effectively trigger this phenomenon, resulting in green, yellow, or red fluorescence [27].

In the natural settings, two key properties enable fluorescent objects to appear notably brighter than their surroundings. First, the difference between excitation and emission of the fluorophores to their non-fluorescent surroundings may cause the objects to appear brighter in certain spectral regions. This effect is further enhanced by a second property: isotropic emission. Since vertical (downwelling) light intensity typically exceeds horizontal light intensity, fluorescent objects that absorb and re-emit this downwelling light uniformly in all directions appear notably brighter against the horizontal background illumination [28]. To maximize the contrast advantages offered by fluorophores, visual detection systems typically focus on narrow spectral regions [10]. In contrast, the intraocular photoreceptors of the human vision possess a broad spectral sensitivity (400-700 nm), requiring the use of specialized filters for optimal visualization of biofluorescent colors [29].

Bioluminescence in Theragnosis of Oral Cavity

Biofilms represent the predominant bacterial framework in dental infections, consisting of mono- or multi-species bacterial communities embedded within a self-produced extracellular polymeric matrix substance (EPS) [30]. The EPS not only facilitates bacterial adhesion to various surfaces but also provides protection against environmental threats. Within the biofilm structure, bacterial cells frequently develop decreased susceptibility to disinfectants and antibiotics. Additionally, the structure facilitates cell-to-cell communication through quorum sensing. Consequently, biofilms have evolved greater resistance compared to their planktonic counterparts, presenting a significant therapeutic challenge [31-33].

Dental biofilm readily develops on various oral surfaces including teeth, implants, orthodontic brackets, root canals, anatomical gaps, and injured soft tissues. These biofilms constitute the primary etiological factor in numerous dental pathologies including caries, periodontal disease, peri-implantitis, mucositis, endodontic failure, and other oral conditions [32,34-37]. When left untreated, these conditions can progress to cause pain, tooth loss, and potentially affect systemic health [38-44]. The detection of early lesions and monitoring disease progression presents significant challenges, even for experienced clinicians. Traditional diagnostic methods, including radiographs and clinical visual or tactile examination, have limitations in detecting subtle changes, such as distinguishing between early caries progression and remineralization [45]. In this context, theragnostic devices, which combine diagnostic and therapeutic capabilities, offer significant advantages in dental practice. Fluorescence-based adjuncts enable real-time detection of biofilm-related biological parameters through non-invasive, user-friendly methods.

Extensive research has identified various endogenous fluorophores in oral bacteria that emit visible light when exposed to ultraviolet irradiation. For instance, Porphyromonas gingivalis (PG), a Gramnegative anaerobic bacterium implicated in periodontal disease and peri-implantitis [46,47], exhibits characteristic red fluorescence [14,48,49]. Aggregatibacter actinomycetemcomitans (AA), a Gramnegative facultative anaerobic bacterium associated with localized aggressive periodontitis and peri-implantitis, displays yellow to orange spectral emissions [50-52]. Streptococcus mutans (SM), a Gram-positive facultative anaerobic bacterium central to dental caries development, produces green fluorescence [14,48,53]. These distinct spectral signatures result from intrinsic photosensitizers: Protoporphyrin IX and coproporphyrin in PG, and flavin adenine dinucleotide (a bacterial energy metabolism product) in SM and AA [54].

Antimicrobial Light – the Current “Magic Bullet”?

A notable characteristic of biological systems containing photosensitizers is their energy emission from the first excited singlet state as fluorescence. This property enables the use of biofluorescence as an antimicrobial tool, supporting both diagnosis-decision making and treatment of oral conditions. Protoporphyrin IX (PpIX), a photosensitizer that accumulates in certain bacteria due to their lack of Ferochelatase enzyme, stimulates the production of singlet oxygen and Reactive Oxygen Species (ROS) in the presence of a light sensitizer, resulting in cytotoxic effects [55]. 5-Aminolevulinic Acid (5-ALA) is an intrinsic photosensitizing agent (differently from toluidine blue and methylene blue), which is converted into an endogenous substance, Protoporphyrin IX, the penultimate molecule to the formation of heme group. This powerful natural photosensitizing molecule has found extensive application in treating cancerous and pre-cancerous conditions [56-60].

The concept of the "Magic Bullet" originated with Paul Ehrlich over a century ago. He envisioned an antimicrobial agent capable of specifically eliminating pathogenic microorganisms while sparing host tissues. His pioneering work led to the development of the first antibiotic [61]. Ehrlich's work was followed by Alexander Fleming and his serendipitous discovery of penicillin which revolutionized medicine [62]. While antibiotics have undeniably saved millions of lives, they present certain limitations including bacterial resistance, side effects, limited tissue penetration, and potential host damage [62].

Antimicrobial light represents an innovative non-antibiotic approach. Its mechanism relies on photoexcitation of endogenous porphyrins (chromophores) in pathogenic microbes, generating intracellular ROS that induce lipid peroxidation and damage to cellular membranes, proteins, and DNA, ultimately leading to microbial death [63]. This multi-target mechanism shows promise in countering antibiotic resistance. Importantly, antimicrobial light demonstrates significantly less toxicity to host cells compared to UVC irradiation [63]. Safety studies consistently show that antimicrobial light exhibits minimal toxicity to mammalian cells while maintaining effectiveness against pathogens [64-66]. Even at high radiant exposures in vivo (>700 J/cm² combined), the technique does not induce mammalian cell apoptosis [64]. Wavelength selection plays a crucial role in achieving optimal results, with different bacteria responding to various wavelengths [64]. Antimicrobial blue light (aBL; 400-470 nm; violet to pure blue colors) demonstrates significant pathogenic cell killing effects, with 405 nm showing the most potent microbicidal properties [66-72]. While longer wavelengths (532-650 nm; green to red colors) show lower bactericidal activity [68], they offer beneficial host effects, including tissue regeneration and pain control, making them valuable as adjunct therapies [64]. Current literature clearly demonstrates that applied bioluminescence offers potent antimicrobial properties across a broad spectrum of microorganisms while maintaining compatibility with traditional antimicrobial approaches [61-64,66,73,74].

Equipment Presentation

REVEAL™ (Designs for Vision, New York, USA), first proposed in 2017 and launched in January 2020 at the Yankee Dental Meeting in Boston, is an advanced diagnostic system combining filtered telescopic lenses with dual daylight/fluorescence 405 nm light technology. The system's transparent, double-filtering design enables handsfree, real-time fluorescence visualization through a sophisticated optical configuration. This includes a restrictive high-pass 430 nm transparent filter at the distal lens opening and an additional proximal filter that attenuates residual magnified blue light.

The REVEAL™ system's versatility allows integration with various telescopic lenses, including panoramic, expanded-field, and refractive infinity view telescopes. The panoramic and expanded-field telescopes mount onto a Ziena glossy black plastic frame, featuring optional anti-splatter black eyecups for peripheral sealing during procedures. The 4.5x Panoramic loupes with Dual Headlight maintain practical usability at 5.9oz/167.3g, while achieving approximately 91% visible light transmission.

The system features a vertically stacked dual headlight attached directly to the loupe frame, delivered in a protective zippered fabric case with conventional foam securing. The battery-powered headlight offers two operating modes:

Single press: Activates conventional white light from the top beam, providing 32,100 lux illumination suitable for all dental procedures; Double press: Engages the 405 nm wavelength bottom beam, activating the fluorescence function

The 405 nm narrow spectrum light stimulates bacterial byproducts associated with caries, calculus, and peri-implantitis, inducing endogenous fluorescence. The filtered LED light system effectively contains energetic light within the housing while transmitting the desired wavelength. The system's minimal heat generation enables extended operational procedures under fluorescence guidance without requiring ambient light reduction.

The complete REVEAL™ Fluorescence Guided Dentistry system comprises:

Reveal Headlight

White headlight: 32,100 lux illumination for standard procedures; Blue excitation headlight: 405 nm narrow spectrum excitation light for bacterial byproduct fluorescence.

Reveal Eyewear

Excitation wavelength filtering for clear fluorescence visualization; 430 nm high-pass filter with 91% visible light transmission; Integrated professional eyeglass prescription.

Magnification

Customized magnification for optimal hands-free operation; Precisely positioned telescopes with through-lens drilling; Adjusted to professional's interpupillary distance; Integrated eyeglass prescription.

Battery Pack

High-capacity power source; User-friendly activation; Compact and lightweight design (Figure 1).